Barr Barred From Premarin Equine-Based Generics; ANDA Status Under Review
Executive Summary
Barr Labs will meet with FDA to discuss the status of its conjugated estrogens ANDA following a district court decision barring the company from using Natural Biologics' raw material for an "AB"-rated generic
You may also be interested in...
Barr Still Betting On Generic Premarin; May Seek Other Estrogen Suppliers
Barr may pursue other raw material suppliers for generic versions of Wyeth's conjugated estrogens product Premarin if a recent court ruling against Barr's supplier Natural Biologics is not overturned on appeal
Barr Still Betting On Generic Premarin; May Seek Other Estrogen Suppliers
Barr may pursue other raw material suppliers for generic versions of Wyeth's conjugated estrogens product Premarin if a recent court ruling against Barr's supplier Natural Biologics is not overturned on appeal
Premarin Generics Reined In; Barr Supplier “Cannot Be Trusted,” Judge Says
Natural Biologics lacks the expertise to reproduce Wyeth's estrogen extraction process for conjugated estrogens (Premarin) by legitimate means, St. Paul, Minn. federal court Judge Joan Ericksen maintained in issuing a permanent injunction against the company